Literature DB >> 880428

Tissue blood flow and distribution of cardiac output in cats: changes caused by intravenous infusions of histamine and histamine receptor agonists.

B M Johnston, D A Owen.   

Abstract

1 The effects of infusions of histamine on blood pressure, cardiac output, heart rate, total peripheral resistance, stroke volume and tissue blood flow have been determined in anaesthetized cats using radio-active microspheres to measure cardiac output and tissue blood flow.2 Histamine caused dose-dependent falls in blood pressure and total peripheral resistance over the dose-range 1 x 10(-8) to 3.3 x 10(-7) mol kg(-1) min(-1). Histamine had no effect on cardiac output, heart rate or stroke volume.3 Histamine caused vasodilatation in the heart and stomach, with increased blood flow through these organs, and in the small and large intestine where blood flow was maintained despite the falls in arterial blood pressure. Blood flow to the brain, kidneys, liver, adrenal glands, skeletal muscle, spleen and skin was reduced when arterial blood pressure fell. Vascular resistance increased in the skin and spleen, presumably due to reflex vasoconstriction when blood pressure fell.4 The selective H(1)-receptor agonist 2-(2-aminoethyl)pyridine lowered blood pressure and decreased total peripheral resistance but did not change cardiac output, heart rate or stroke volume. 2-(2-Aminoethyl)pyridine caused vasodilatation in the heart, small and large intestine and kidneys. Vascular resistance was increased in the spleen and skin.5 The selective H(2)-receptor agonist 4-methylhistamine also lowered blood pressure and decreased total peripheral resistance but did not change cardiac output, heart rate or stroke volume. 4-Methylhistamine caused vasodilatation in the heart, stomach, small and large intestines and skeletal muscle. Vascular resistance was increased in the skin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 880428      PMCID: PMC1667415          DOI: 10.1111/j.1476-5381.1977.tb07738.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  THE EFFECT OF SOME PHYSIOLOGICAL VASODILATORS ON THE VASCULAR BED OF SKELETAL MUSCLE.

Authors:  I KJELLMER; H ODELRAM
Journal:  Acta Physiol Scand       Date:  1965 Jan-Feb

2.  Effect of histamine on small and large vessel pressures in the dog foreleg.

Authors:  F J HADDY
Journal:  Am J Physiol       Date:  1960-01

3.  Cardiac output, arterial blood pressure and pulmonary arterial pressure in histamine shock.

Authors:  A L DELAUNOIS; R KORDECKI; H POLET; J RYZEWSKI
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-05-01

4.  Microscopic observations on the action of histamine on small blood vessels.

Authors:  J S LEE
Journal:  Am J Physiol       Date:  1957-09

5.  Histamine shock.

Authors:  H H Dale; P P Laidlaw
Journal:  J Physiol       Date:  1919-03-25       Impact factor: 5.182

6.  The physiological action of beta-iminazolylethylamine.

Authors:  H H Dale; P P Laidlaw
Journal:  J Physiol       Date:  1910-12-31       Impact factor: 5.182

7.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

8.  The circulation of the fetus in utero. Methods for studying distribution of blood flow, cardiac output and organ blood flow.

Authors:  A M Rudolph; M A Heymann
Journal:  Circ Res       Date:  1967-08       Impact factor: 17.367

9.  Gastric blood flow in anaesthetized cats.

Authors:  A A Harper; J D Reed; J R Smy
Journal:  J Physiol       Date:  1968-02       Impact factor: 5.182

10.  Comparison of gastrin and histamine on gastric mucosal blood flow.

Authors:  E D Jacobson; A C Chang
Journal:  Proc Soc Exp Biol Med       Date:  1969-02
View more
  12 in total

1.  The cardiovascular response to dimaprit, a selective histamine H2-receptor agonist.

Authors:  S B Flynn; B M Johnston; D A Owen
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

2.  In vivo pharmacological studies with SK&F 94836, a potent inotrope/vasodilator with a sustained duration of action.

Authors:  R W Gristwood; M B Comer; R J Eden; E M Taylor; J A Turner; M Wallduck; D A Owen
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

3.  Histamine H1- and H2-receptors in the gastrointestinal circulation.

Authors:  G A Charbon; H A Brouwers; A Sala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

Review 4.  An update on histamine receptors and the gastrointestinal tract.

Authors:  B I Hirschowitz
Journal:  Dig Dis Sci       Date:  1985-10       Impact factor: 3.199

5.  Redistribution of cardiac output during localized granulomatous inflammation and the effect of methysergide in anesthetized rats.

Authors:  L D De Leve; M J Parnham; P R Saxena
Journal:  Inflammation       Date:  1980-12       Impact factor: 4.092

6.  Cardiac output and regional blood flow studies in golden hamsters.

Authors:  O P Gulati; G Ponard
Journal:  Experientia       Date:  1980-08-15

7.  Mesenteric vascular reactivity to histamine receptor agonists and antagonists.

Authors:  K M Walus; J D Fondacaro; E D Jacobson
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199

8.  The effect of ergotamine on tissue blood flow and the arteriovenous shunting of radioactive microspheres in the head.

Authors:  B M Johnston; P R Saxena
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

9.  Temporal responses of cutaneous blood flow and plasma catecholamine concentrations to histamine H1- or H2-receptor stimulation in man.

Authors:  U Knigge; B Alsbjørn; B Thuesen; O Siemssen; P M Christiansen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

10.  Angiotensin II-Induced End-Organ Damage in Mice Is Attenuated by Human Exosomes and by an Exosomal Y RNA Fragment.

Authors:  Linda Cambier; Jorge F Giani; Weixin Liu; Takeshi Ijichi; Antonio K Echavez; Jackelyn Valle; Eduardo Marbán
Journal:  Hypertension       Date:  2018-06-04       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.